FINCH THERAPEUTICS GROUP INC's ticker is FNCH and the CUSIP is 31773D101. A total of 44 filers reported holding FINCH THERAPEUTICS GROUP INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $9,927 | -18.1% | 25,259 | 0.0% | 0.00% | – |
| Q4 2022 | $12,124 | -71.1% | 25,259 | 0.0% | 0.00% | – |
| Q3 2022 | $42,000 | +5.0% | 25,259 | +77.3% | 0.00% | – |
| Q2 2022 | $40,000 | -87.7% | 14,243 | -78.0% | 0.00% | – |
| Q1 2022 | $326,000 | -51.5% | 64,821 | -3.9% | 0.00% | – |
| Q4 2021 | $672,000 | -25.4% | 67,445 | -2.7% | 0.00% | – |
| Q3 2021 | $901,000 | -15.8% | 69,293 | -8.9% | 0.00% | – |
| Q2 2021 | $1,070,000 | – | 76,058 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avenir Management Company, LLC | 55,445 | $472,946 | 1.27% |